
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1063 | 991 | 982 | 1064 | 1434 | 1624 |
Fund Return | 6.35% | -0.87% | -1.75% | 2.1% | 7.47% | 4.97% |
Place in category | 321 | 447 | 658 | 332 | 175 | 157 |
% in Category | 41 | 55 | 73 | 49 | 34 | 58 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPI Global Income Fund C dist USD h | 17.49B | 2.03 | 3.36 | 4.59 | ||
Global Income Fund C div USD hedged | 17.49B | 2.03 | 3.37 | 4.60 | ||
JPI Global Income Fund A div USD he | 17.49B | 1.96 | 3.34 | 3.71 | ||
JPI Global Income Fund A mth USD he | 17.49B | 1.95 | 3.32 | 3.69 | ||
JPI Global Income Fund C acc USD he | 17.49B | 2.06 | 4.02 | 4.39 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
World Healthscience Fund C2u | 399.03M | 7.12 | 3.81 | 5.84 | ||
World Healthscience Fund D2u | 1.26B | 7.46 | 5.90 | 7.98 | ||
World Healthscience Fund X2 USD | 44.79M | 7.63 | 6.94 | 9.06 | ||
World Healthscience Fund A2 | 6.81B | 7.33 | 5.11 | 7.17 | ||
World Healthscience Fund E2 | 2.23B | 7.24 | 4.59 | 6.64 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 10.18 | 821.67 | -0.62% | |
UnitedHealth | US91324P1021 | 7.09 | 515.72 | -0.48% | |
AbbVie | US00287Y1091 | 6.69 | 202.72 | +0.71% | |
J&J | US4781601046 | 6.25 | 163.13 | +0.87% | |
AstraZeneca | GB0009895292 | 5.08 | 11,196.0 | -0.32% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review